GENE ONLINE|News &
Opinion
Blog

2017-11-03|

November 3, 1950: American Biochemist James Rothman was Born

by GeneOnline
Share To

James Rothman (November 3, 1950 – present) is an American biochemist. He is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University and the Chairman of the Department of Cell Biology at Yale School of Medicine. Rothman dedicates his career in studying intracellular and extracellular vesicles and the trafficking mechanism. Rothman had a great contribution in discoverying how the sac-like structures within and between cells precisely transport hormones, growth factors, and other molecules to correlated destination. Rothman jointly received the 2013 Nobel Prize in Physiology or Medicine with Randy Schekman and Thomas C. Südhof for their work on vesicle trafficking. He has also received many other honors, including the King Faisal International Prize in 1996, the Louisa Gross Horwitz Prize from Columbia University and the Albert Lasker Award for Basic Medical Research both in 2002.

Reference

https://www.nobelprize.org/nobel_prizes/medicine/laureates/2013/rothman-bio.html https://en.wikipedia.org/wiki/James_Rothman

Image Source

http://fmri.org/commentary/

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
Three Scientists Jointly Win Nobel Prize for Innovations in Click Chemistry
2022-10-06
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!